David Pyring

Design and Synthesis of β-Site Amyloid Precursor Protein Cleaving Enzyme (BACE1) Inhibitors with in Vivo Brain Reduction of β-Amyloid Peptides

Britt‐Marie Swahn, Karin Kolmodin, Sofia Karlström et al. · Journal of Medicinal Chemistry · 2012 · 100 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +17

The discovery of 2-anilinothiazolones as 11β-HSD1 inhibitors

Chester Yuan, David J. St. Jean, Qingyian Liu et al. · Bioorganic & Medicinal Chemistry Letters · 2007 · 41 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +10

Synthesis and evaluation of 2-pyridylbenzothiazole, 2-pyridylbenzoxazole and 2-pyridylbenzofuran derivatives as 11C-PET imaging agents for β-amyloid plaques

Britt‐Marie Swahn, David Wensbo, Johan Sandell et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 30 citations · Full text

Medicine, Nuclear Medicine, Pharmacology +15

Synthesis and evaluation of pyridylbenzofuran, pyridylbenzothiazole and pyridylbenzoxazole derivatives as 18F-PET imaging agents for β-amyloid plaques

Britt‐Marie Swahn, Johan Sandell, David Pyring et al. · Bioorganic & Medicinal Chemistry Letters · 2012 · 25 citations · Full text

Medicine, Medicinal Chemistry, Nuclear Medicine +16

Design and Synthesis of Potent <i>C</i>₂-Symmetric Diol-Based HIV-1 Protease Inhibitors:  Effects of Fluoro Substitution

David Pyring, Jimmy Lindberg, Åsa Rosenquist et al. · Journal of Medicinal Chemistry · 2001 · 25 citations · Full text

Pharmacy, Medicinal Chemistry, Pharmacology +13